Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Imazio

Showing results (241-250 of 483) with videos related to

Pageof 49
Sort By:
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|June 18, 2002
Uncomplicated non-Q wave myocardial infarction: long-term prognosis with a conservative echo-stress guided management strategyEnrico Cecchi, Giovanni Brusasco, Massimo Tidu, et al.
BMC Cardiovascular Disorders|January 25, 2020
Anticoagulant and anti-thrombotic therapy in acute type B aortic dissection: when real-life scenarios face the shadows of the evidence-based medicinePier Paolo Bocchino, Ovidio De Filippo, Francesco Piroli, et al.
Heart (British Cardiac Society)|June 6, 2020
COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?Massimo Imazio, Karin Klingel, Ingrid Kindermann, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 29, 2007
Rationale and design of the COPPS trial: a randomised, placebo-controlled, multicentre study on the use of colchicine for the primary prevention of postpericardiotomy syndromeMassimo Imazio, Enrico Cecchi, Brunella Demichelis, et al.
International Journal of Cardiology|March 12, 2017
Phenotypic expression of ARVC: How 12 lead ECG can predict left or right ventricle involvement. A familiar case series and a review of literatureLuca Gaido, Alberto Battaglia, Mario Matta, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 8, 2010
Cardiovascular-associated disease in an addicted population: an observation studyDaniela Demarie, Giovanna Marletta, Massimo Imazio, et al.
Current Cardiology Reports|June 16, 2018
Use of Interleukin-1 Blockers in Pericardial and Cardiovascular DiseasesGiacomo Emmi, Maria Letizia Urban, Massimo Imazio, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 23, 2013
DRainage Or Pericardiocentesis alone for recurrent nonmalignant, nonbacterial pericardial effusions requiring intervention: rationale and design of the DROP trial, a randomized, open-label, multicenter studyMassimo Imazio, Riccardo Belli, Federico Beqaraj, et al.
Giornale Italiano Di Cardiologia (2006)|December 12, 2022
[Anti-inflammatory therapies for cardiovascular diseases: novel evidence, clinical implications, and future perspectives]Felice Gragnano, Paolo Calabrò, Vincenzo De Sio, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 7, 2026
Arrhythmic Myocarditis and Prevention of Sudden Cardiac Death: Current Evidence, Risk Stratification, and ManagementMassimo Imazio, Valentino Collini, Mariacristina Tomat, et al.
Pageof 49

Showing results (241-250 of 483) with videos related to

Sort By:
Pageof 49
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|June 18, 2002
Uncomplicated non-Q wave myocardial infarction: long-term prognosis with a conservative echo-stress guided management strategyEnrico Cecchi, Giovanni Brusasco, Massimo Tidu, et al.
BMC Cardiovascular Disorders|January 25, 2020
Anticoagulant and anti-thrombotic therapy in acute type B aortic dissection: when real-life scenarios face the shadows of the evidence-based medicinePier Paolo Bocchino, Ovidio De Filippo, Francesco Piroli, et al.
Heart (British Cardiac Society)|June 6, 2020
COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?Massimo Imazio, Karin Klingel, Ingrid Kindermann, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 29, 2007
Rationale and design of the COPPS trial: a randomised, placebo-controlled, multicentre study on the use of colchicine for the primary prevention of postpericardiotomy syndromeMassimo Imazio, Enrico Cecchi, Brunella Demichelis, et al.
International Journal of Cardiology|March 12, 2017
Phenotypic expression of ARVC: How 12 lead ECG can predict left or right ventricle involvement. A familiar case series and a review of literatureLuca Gaido, Alberto Battaglia, Mario Matta, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 8, 2010
Cardiovascular-associated disease in an addicted population: an observation studyDaniela Demarie, Giovanna Marletta, Massimo Imazio, et al.
Current Cardiology Reports|June 16, 2018
Use of Interleukin-1 Blockers in Pericardial and Cardiovascular DiseasesGiacomo Emmi, Maria Letizia Urban, Massimo Imazio, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 23, 2013
DRainage Or Pericardiocentesis alone for recurrent nonmalignant, nonbacterial pericardial effusions requiring intervention: rationale and design of the DROP trial, a randomized, open-label, multicenter studyMassimo Imazio, Riccardo Belli, Federico Beqaraj, et al.
Giornale Italiano Di Cardiologia (2006)|December 12, 2022
[Anti-inflammatory therapies for cardiovascular diseases: novel evidence, clinical implications, and future perspectives]Felice Gragnano, Paolo Calabrò, Vincenzo De Sio, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 7, 2026
Arrhythmic Myocarditis and Prevention of Sudden Cardiac Death: Current Evidence, Risk Stratification, and ManagementMassimo Imazio, Valentino Collini, Mariacristina Tomat, et al.
Pageof 49